CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and Progression.
Sign Up to like & getrecommendations! Published in 2025 at "Neurology"
DOI: 10.1212/wnl.0000000000214346
Abstract: BACKGROUND AND OBJECTIVES α-Synuclein (αSyn) seed amplification assays (SAAs) accurately detect αSyn pathology in dementia with Lewy bodies (DLB). Alzheimer disease (AD) copathology occurs in ∼70% of patients with DLB at autopsy. The association of… read more here.
Keywords: year; seed; saa participants; syn saa ... See more keywords